GO | Name |
GO:0001501 | skeletal system development |
GO:0001503 | ossification |
GO:0003272 | endocardial cushion formation |
GO:0003323 | type B pancreatic cell development |
GO:0003344 | pericardium morphogenesis |
GO:0005125 | cytokine activity |
GO:0005615 | extracellular space |
GO:0008083 | growth factor activity |
GO:0008284 | positive regulation of cell population proliferation |
GO:0008285 | negative regulation of cell population proliferation |
GO:0010719 | negative regulation of epithelial to mesenchymal transition |
GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation |
GO:0010894 | negative regulation of steroid biosynthetic process |
GO:0021502 | neural fold elevation formation |
GO:0030509 | BMP signaling pathway |
GO:0030902 | hindbrain development |
GO:0031982 | vesicle |
GO:0032348 | negative regulation of aldosterone biosynthetic process |
GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway |
GO:0045944 | positive regulation of transcription by RNA polymerase II |
GO:0048738 | cardiac muscle tissue development |
GO:0050679 | positive regulation of epithelial cell proliferation |
GO:0051216 | cartilage development |
GO:0060037 | pharyngeal system development |
GO:0060395 | SMAD protein signal transduction |
GO:0060411 | cardiac septum morphogenesis |
GO:0060710 | chorio-allantoic fusion |
GO:0061384 | heart trabecula morphogenesis |
GO:0070700 | BMP receptor binding |
GO:0071676 | negative regulation of mononuclear cell migration |
GO:1900006 | positive regulation of dendrite development |
GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:1905069 | allantois development |
GO:2000065 | negative regulation of cortisol biosynthetic process |